» Articles » PMID: 11044365

Bcl-2/Bax Protein Ratio Predicts 5-fluorouracil Sensitivity Independently of P53 Status

Overview
Journal Br J Cancer
Specialty Oncology
Date 2000 Oct 25
PMID 11044365
Citations 17
Authors
Affiliations
Soon will be listed here.
Abstract

p53 tumour-suppressor gene is involved in cell growth control, arrest and apoptosis. Nevertheless cell cycle arrest and apoptosis induction can be observed in p53-defective cells after exposure to DNA-damaging agents such as 5-fluorouracil (5-FU) suggesting the importance of alternative pathways via p53-independent mechanisms. In order to establish relationship between p53 status, cell cycle arrest, Bcl-2/Bax regulation and 5-FU sensitivity, we examined p53 mRNA and protein expression and p53 protein functionality in wild-type (wt) and mutant (mt) p53 cell lines. p53 mRNA and p53 protein expression were determined before and after exposure to equitoxic 5-FU concentration in six human carcinoma cell lines differing in p53 status and displaying marked differences in 5-FU sensitivity, with IC(50)values ranging from 0.2-22.6 mM. 5-FU induced a rise in p53 mRNA expression in mt p53 cell lines and in human papilloma virus positive wt p53 cell line, whereas significant decrease in p53 mRNA expression was found in wt p53 cell line. Whatever p53 status, 5-FU altered p53 transcriptional and translational regulation leading to up-regulation of p53 protein. In relation with p53 functionality, but independently of p53 mutational status, after exposure to 5-FU equitoxic concentration, all cell lines were able to arrest in G1. No relationship was evidenced between G1 accumulation ability and 5-FU sensitivity. Moreover, after 5-FU exposure, Bax and Bcl-2 proteins regulation was under p53 protein control and a statistically significant relationship (r = 0.880, P = 0.0097) was observed between Bcl-2/Bax ratio and 5-FU sensitivity. In conclusion, whatever p53 status, Bcl-2 or Bax induction and Bcl-2/Bax protein ratio were correlated to 5-FU sensitivity.

Citing Articles

Comprehensive molecular analysis of 26 newly established human pancreatic ductal adenocarcinoma cell lines reveals two clusters with variating drug sensitivities.

Maeng J, Kim J, Kim S, Yun W, Kwon W, Han Y Cancer Cell Int. 2025; 25(1):53.

PMID: 39972450 PMC: 11837577. DOI: 10.1186/s12935-025-03671-8.


PYGO2 promotes resistance to chemotherapy via reducing apoptosis and G2/M cell cycle arrest in esophageal carcinoma cells.

Ardalan Moghadam Al F, Forghanifard M, Zarrinpour V Med Oncol. 2025; 42(2):45.

PMID: 39808374 DOI: 10.1007/s12032-024-02590-4.


Activity Changes of the Peptic Lactoferrin Hydrolysate in Human Gastric Cancer AGS Cells in Response to Cu(II) or Mn(II) Addition.

Bo L, Pan Z, Zhang Q, Song C, Ren J, Zhao X Foods. 2023; 12(14).

PMID: 37509754 PMC: 10378690. DOI: 10.3390/foods12142662.


Nrf2-siRNA Enhanced the Anti-Tumor Effects of AsO in 5-Fluorouracil-Resistant Hepatocellular Carcinoma by Inhibiting HIF-1α/HSP70 Signaling.

Duan X, Xu W, Li H, Wang M, Wang W, Lu H J Hepatocell Carcinoma. 2022; 9:1341-1352.

PMID: 36575732 PMC: 9790171. DOI: 10.2147/JHC.S388077.


The Inhibitory Response to PI3K/AKT Pathway Inhibitors MK-2206 and Buparlisib Is Related to Genetic Differences in Pancreatic Ductal Adenocarcinoma Cell Lines.

Ma Y, Sender S, Sekora A, Kong W, Bauer P, Ameziane N Int J Mol Sci. 2022; 23(8).

PMID: 35457111 PMC: 9029322. DOI: 10.3390/ijms23084295.


References
1.
OConnor P, Jackman J, Jondle D, Bhatia K, Magrath I, Kohn K . Role of the p53 tumor suppressor gene in cell cycle arrest and radiosensitivity of Burkitt's lymphoma cell lines. Cancer Res. 1993; 53(20):4776-80. View

2.
Barak Y, Juven T, Haffner R, Oren M . mdm2 expression is induced by wild type p53 activity. EMBO J. 1993; 12(2):461-8. PMC: 413229. DOI: 10.1002/j.1460-2075.1993.tb05678.x. View

3.
El-Deiry W, Tokino T, Velculescu V, Levy D, Parsons R, Trent J . WAF1, a potential mediator of p53 tumor suppression. Cell. 1993; 75(4):817-25. DOI: 10.1016/0092-8674(93)90500-p. View

4.
Barberi-Heyob M, Griffon G, Merlin J, Weber B . Sequence-dependent growth-inhibitory effects of the in vitro combination of fluorouracil, cisplatin, and dipyridamole. Cancer Chemother Pharmacol. 1993; 33(2):163-70. DOI: 10.1007/BF00685336. View

5.
Reed J . Bcl-2 and the regulation of programmed cell death. J Cell Biol. 1994; 124(1-2):1-6. PMC: 2119888. DOI: 10.1083/jcb.124.1.1. View